Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer N Engl J Med 2018; 378:2078-2092 Abstract<BACKGROUND>First-line therapy for advanced non–small-cell lung cancer (NSCLC) that lacks targetable mutations is platinum-based chemothe</background>…

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial ARTICLES| VOLUME 401, ISSUE 10378, P733-746, MARCH 04, 2023 THE LANCET Summary <Background>Sotorasib is a spec</background>…